The week in health tech, explained in plain English.Get the free newsletter →
October 23, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Payers

Care Transitions Emerge as Key Lever for MA Star Ratings

Medicare Advantage plans are zeroing in on care transitions as a way to defend their Star Ratings, according to Healthcare Dive. The moments after a patient leaves a hospital or skilled nursing facility are when things fall apart: missed follow-ups, medication errors, and avoidable readmissions. Those failures show up directly in the measures CMS uses to score plans.

Star Ratings matter because they drive real money. Higher-rated plans earn quality bonus payments and can reinvest in richer benefits, while low scores erode enrollment and revenue. As CMS tightens its methodology and cut points, plans have less room to coast, so leading insurers are building tighter handoffs between hospitals, post-acute providers, and primary care.

In practice, that means proactive outreach after discharge, medication reconciliation, and closing gaps before they become readmissions. The payoff is twofold: better clinical outcomes on measures like readmission rates, and stronger member-experience scores that now carry heavy weight in the overall rating.

More in Payers

Payers

CMS Releases 2027 Medicare Advantage Star Ratings

CMS released its 2027 Medicare Advantage star ratings on Oct. 8, shaping quality bonus payments and how insurers compete for members.

Why it matters: Star ratings control billions in quality bonus payments that determine how generous Medicare Advantage plans can be.

Payers

Walmart to Make Some GLP-1s Free for Diabetic Workers in 2027

Walmart will make more than 250 medications, including some GLP-1s for Type 2 diabetes, free to employees starting in 2027.

Why it matters: How a major self-insured employer like Walmart structures GLP-1 coverage signals where corporate drug benefits are heading amid soaring demand.

Payers

Patients Are Taking Insurance Denials Straight to the C-Suite

Some patients are overturning insurance denials by emailing insurer CEOs directly, a workaround that exposes deeper flaws in the standard appeals process.

Why it matters: When patients must reach the CEO to get covered care approved, it signals the normal denial and appeals system is failing the people it should serve.